Mead Johnson Nutrition Co. (MJN) Misses Q3 EPS by 1c; Trims Outlook
Get Alerts MJN Hot Sheet
Join SI Premium – FREE
Mead Johnson Nutrition Co. (NYSE: MJN) reported Q3 EPS of $0.71, $0.01 worse than the analyst estimate of $0.72. Revenue for the quarter came in at $921.3 million versus the consensus estimate of $974.25 million.
Mead Johnson Nutrition Co. sees FY2012 EPS of $3.02-3.07, versus prior guidance of $3.04-3.17 and the consensus of $3.10.
For earnings history and earnings-related data on Mead Johnson Nutrition Co. (MJN) click here.
Mead Johnson Nutrition Co. sees FY2012 EPS of $3.02-3.07, versus prior guidance of $3.04-3.17 and the consensus of $3.10.
For earnings history and earnings-related data on Mead Johnson Nutrition Co. (MJN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
- ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share